Generic Release Date:

Relexxii's generic launch date based on the expiry of its last outstanding patent is estimated to be Feb 03, 2037 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Relexxii Generic API suppliers:

Methylphenidate Hydrochloride is the generic name for the brand Relexxii. 42 different companies have already filed for the generic of Relexxii, with Specgx Llc having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Relexxii's generic

Alternative Brands for Relexxii

There are several other brand drugs using the same active ingredient (Methylphenidate Hydrochloride) as Relexxii. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.

Apart from brand drugs containing the same ingredient, some generics have also been filed for Methylphenidate Hydrochloride, Relexxii's active ingredient. Check the complete list of approved generic manufacturers for Relexxii

Approval Date:

Relexxii was approved by FDA for market use on 23 June, 2022.

Active Ingredient:

Relexxii uses Methylphenidate Hydrochloride as the active ingredient. Check out other Drugs and Companies using Methylphenidate Hydrochloride ingredient

Dosage:

Relexxii is available in tablet, extended release form for oral use. Given below is detailed information on Dosage -